Elite in Brain Tumor

Dr. Steven S. Brem

Neurosurgery
3400 Spruce Street, 3 Silverstein Building, 
Philadelphia, PA 
Elite in Brain Tumor
3400 Spruce Street, 3 Silverstein Building, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Brem is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Brem is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 63 articles and participated in 2 clinical trials in the study of Brain Tumor.

Specialties
Neurosurgery
Licenses
Neurological Surgery in PA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

3400 Spruce Street, 3 Silverstein Building, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: INO-5401, INO-9012, Cemiplimab, Temozolomide
Study Phase: Phase 1/Phase 2
Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel® Wafer (Carmustine Implant) Used in Usual Medical Practice
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Radiation, Biological, Other, Drug
Study Drugs: AdV-tk, Valacyclovir, Temozolomide, Nivolumab
Study Phase: Phase 1
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Other
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

107 Total Publications

Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma.
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for Glioblastoma.
Journal: JCO precision oncology
Published: September 04, 2025
Similar Doctors
Elite in Brain Tumor
Dr. Donald M. O'rourke
Neurosurgery
Elite in Brain Tumor
Dr. Donald M. O'rourke
Neurosurgery

Penn Gamma Knife Center

801 Spruce Street, Spruce Building, 1st Floor, 
Philadelphia, PA 
 (2.1 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald O'rourke is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. O'rourke is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy. Dr. O'rourke is currently accepting new patients.

Elite in Brain Tumor
Dr. David W. Andrews
Neurosurgery
Elite in Brain Tumor
Dr. David W. Andrews
Neurosurgery

Jefferson University Physicians

111 S 11th St, 
Philadelphia, PA 
 (1.9 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Andrews is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Andrews is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Meningioma, Glioblastoma, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Elite in Brain Tumor
Dr. Nduka M. Amankulor
Neurosurgery
Elite in Brain Tumor
Dr. Nduka M. Amankulor
Neurosurgery

Penn Neuroscience Center - Neurosurgery

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.2 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nduka Amankulor is a Neurosurgery provider in Philadelphia, Pennsylvania. Dr. Amankulor is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Amankulor is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brem's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile